[Soft tissue sarcoma: isolated hyperthermic extremity perfusion. Technique and indications].
Schlag
P M
PM
Universitätsklinikum Rudolf Virchow, Robert-Rössle-Klinik für Onkologie am Max-Delbrück-Centrum für Molekulare Medizin, Berlin-Buch.
Kettelhack
C
C
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D010478:Chemotherapy, Cancer, Regional Perfusion; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005121:Extremities; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*
D004317:Doxorubicin; D002945:Cisplatin; D008558:Melphalan
Weichteilsarkome: Die isolierte hypertherme Extremitätenperfusion. Technik und Indikationen.